The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identification of putative germline mutations in 10,288 patients undergoing circulating tumor DNA testing.
 
Thomas Paul Slavin
No Relationships to Disclose
 
Kimberly Banks
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Patents, Royalties, Other Intellectual Property - Guardant Health
 
Darya Chudova
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Patents, Royalties, Other Intellectual Property - Guardant Health
 
Geoffrey R. Oxnard
Honoraria - AstraZeneca; Chugai Pharma
Consulting or Advisory Role - ARIAD; AstraZeneca; Boehringer Ingelheim; Genentech/Roche; Inivata; Sysmex; Takeda
Patents, Royalties, Other Intellectual Property - DFCI has a patent pending titled "Non-invasive blood-based monitoring of genomic alterations in cancer", on which I am a co-author. (Inst)
 
Justin I. Odegaard
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Rebecca J Nagy
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Patents, Royalties, Other Intellectual Property - Guardant Health
 
Susan L. Neuhausen
No Relationships to Disclose
 
Stacy W. Gray
No Relationships to Disclose
 
Massimo Cristofanilli
Honoraria - Agendia; Celgene; Dompé Farmaceutici; Pfizer
Consulting or Advisory Role - Cynvenio Biosystems; Dompé Farmaceutici; Newomics; Vortex Biosciences
 
Angel Augusto Rodriguez
Honoraria - Guardant Health
 
Aditya Bardia
Consulting or Advisory Role - Genentech; Novartis
 
Brian Leyland-Jones
Stock and Other Ownership Interests - Aeterna Zentaris; ARIAD; Catalyst Pharmaceuticals; Mannkind; Progenix; Puma Biotechnology; Sucampo Pharmaceuticals
Consulting or Advisory Role - Amgen
Speakers' Bureau - Genentech
Expert Testimony - Amgen
 
Mike Janicek
Leadership - Honor Health
Stock and Other Ownership Interests - Clovis Oncology; Intuitive Surgical; Myriad Genetics
Consulting or Advisory Role - Ambry Genetics; Guardant Health
Speakers' Bureau - AstraZeneca; Clovis Oncology
 
Michael B. Lilly
No Relationships to Disclose
 
Guru Sonpavde
Honoraria - UpToDate
Consulting or Advisory Role - Agensys; Amgen; Argos Therapeutics; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Janssen; Merck; Novartis; Pfizer; Sanofi
Speakers' Bureau - Clinical Care Options/NCCN
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Merck (Inst); Onyx (Inst)
Other Relationship - Boehringer Ingelheim
 
Christine E. Lee
Employment - Guardant Health; Myriad Genetics
Stock and Other Ownership Interests - Guardant Health; Myriad Genetics
 
Richard B. Lanman
Employment - Guardant Health; Veracyte
Leadership - Guardant Health
Stock and Other Ownership Interests - Guardant Health; Veracyte
Research Funding - Guardant Health
 
Funda Meric-Bernstam
Honoraria - Genentech; Roche
Consulting or Advisory Role - Celgene; Clearlight Diagnostics; Genentech; Inflection Biosciences; Novartis; Pieris Pharmaceuticals; Roche
Research Funding - Aileron Therapeutics; AstraZeneca; Bayer; Calithera Biosciences; Curis; CytomX Therapeutics; Debiopharm Group; Effective Pharmaceuticals; Genentech; Jounce Therapeutics; Novartis; PUMA Biotechnology; Taiho Pharmaceutical; Verastem; Zymeworks
 
Razelle Kurzrock
Leadership - CureMatch
Stock and Other Ownership Interests - Actuate Therapeutics; CureMatch
Honoraria - AACR; AACR; Actuate Therapeutics; Casdin Capital; Casdin Capital; Casdin Capital; Casdin Capital; Cedars-Sinai; Frankel Group; Global Biomarkers Consortium; Health Advances; Janssen; Jubilant Biosys; Kaiser Permanente; Mayo Clinic Cancer Center; NCCN; Northwestern University; NXT Health Strategies; NXT Health Strategies; Pancreatic Cancer Action Network; Segal Cancer Center; Seminars in Oncology; Sequenom; Sequenom; Sequenom; Sequenom; Sequenom; Sequenom; Sequenom; Sylvester Cancer Center; Sylvester Cancer Center; The Dedham Group; UCSD Genomics Program Talk; XBiotech; XBiotech; Yale Cancer Center
Consulting or Advisory Role - AACR; Actuate Therapeutics; CTRC-EAB San Antonio; Janssen; Jubilant Biosys; Merck; SAIC NCI CCCT IDSE; Sequenom; XBiotech
Research Funding - Centocor Ortho Biotech; EMD Serono; EMD Serono; EMD Serono; Exelixis; Foundation Medicine; Genentech Mypath; GlaxoSmithKline; GlaxoSmithKline; Guardant Health; Merck; Merck; Merck Serono; Novartis; Pfizer; Roche/Genentech; Sequenom; XBiotech
Patents, Royalties, Other Intellectual Property - Patent; Patent; Patent; Patent
Travel, Accommodations, Expenses - AACR; AACR; ASCPT; Association of American Cancer Institutes; Caris Centers of Excellence; Caris Centers of Excellence; Cedars-Sinai; CureMatch; EMD Serono; EMD Serono & Quintiles; EMD Serono & Quintiles; FDA-OCRA; Gateway Research Advisory Committee; Gateway Research Advisory Committee; Genentech; Global Biomarkers Consortium; Global Source Ventures/Novena Therapeutics; Guardant Health; Guardant Health; ICRP; Journal of Precision Medicine; Kaiser Permanente; Lynx Group; Mayo Clinic Cancer Center; MedImmune/JK Associates Medical Communications Group; Meyer; Orbimed/Global Source Ventures; Pancreatic Cancer Action Network; Sylvester Cancer Center; WIN Pharma; WIN Pharma; WIN Pharma; WIN Pharma; WIN Pharma; WIN Pharma; WIN Pharma; WIN Pharma
 
Jeffrey N. Weitzel
No Relationships to Disclose